Cervical adenoid basal carcinoma

disease

On this page

Also known as adenoid basal carcinoma of the cervix utericervical adenoid basal cancerskin adenoid basal cell carcinoma of uterine cervixuterine cervix skin adenoid basal cell carcinoma

Summary

Cervical adenoid basal carcinoma (MONDO:0006132) is a cancer. A subtype of skin adenoid basal cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cervical adenoid basal carcinoma
Mondo ID	MONDO:0006132
EFO	EFO:1000160
Orphanet	213828
DOID	DOID:6428
NCIT	C40213
UMLS	C1516403
MedGen	275704
GARD	0020499
Anatomy (UBERON)	UBERON:0000002
Is cancer (heuristic)	yes

Also known as: adenoid basal carcinoma of the cervix uteri · cervical adenoid basal cancer · cervical adenoid basal carcinoma · skin adenoid basal cell carcinoma of uterine cervix · uterine cervix skin adenoid basal cell carcinoma

Disease family

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › integumentary system cancer › skin cancer › skin carcinoma › skin basal cell carcinoma › skin adenoid basal cell carcinoma › cervical adenoid basal carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.